BOV Stock Overview
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Apyx Medical Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.12 |
52 Week High | US$6.95 |
52 Week Low | US$1.09 |
Beta | 1.12 |
1 Month Change | -41.67% |
3 Month Change | -46.15% |
1 Year Change | -58.21% |
3 Year Change | -86.26% |
5 Year Change | -70.53% |
Change since IPO | -80.85% |
Recent News & Updates
Recent updates
Shareholder Returns
BOV | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -29.1% | -1.2% | 1.9% |
1Y | -58.2% | 4.3% | 7.3% |
Return vs Industry: BOV underperformed the German Medical Equipment industry which returned 2.8% over the past year.
Return vs Market: BOV underperformed the German Market which returned 6.4% over the past year.
Price Volatility
BOV volatility | |
---|---|
BOV Average Weekly Movement | 15.3% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BOV's share price has been volatile over the past 3 months.
Volatility Over Time: BOV's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1982 | 252 | Charlie Goodwin | https://www.apyxmedical.com |
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.
Apyx Medical Corporation Fundamentals Summary
BOV fundamental statistics | |
---|---|
Market cap | €40.62m |
Earnings (TTM) | -€17.28m |
Revenue (TTM) | €48.33m |
0.8x
P/S Ratio-2.4x
P/E RatioIs BOV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BOV income statement (TTM) | |
---|---|
Revenue | US$52.35m |
Cost of Revenue | US$18.59m |
Gross Profit | US$33.76m |
Other Expenses | US$52.47m |
Earnings | -US$18.71m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.54 |
Gross Margin | 64.49% |
Net Profit Margin | -35.75% |
Debt/Equity Ratio | 123.3% |
How did BOV perform over the long term?
See historical performance and comparison